| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.21B | -2.0% |
| Cost of Revenue | $2.60B | -1.2% |
| Gross Profit | $1.61B | -3.2% |
| R&D Expense | $243.5M | +10.9% |
| SG&A Expense | $422.2M | +48.1% |
| Operating Income | $289.2M | -46.1% |
| Interest Expense | $70.7M | -21.2% |
| Pre-tax Income | $199.1M | -51.4% |
| Income Tax | $37.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $341.4M | +21.4% |
| Accounts Receivable | $602.7M | -1.5% |
| Inventory | $1.25B | +21.1% |
| Current Assets | $2.46B | +21.2% |
| Total Assets | $5.57B | +9.1% |
| Current Liabilities | $1.22B | +17.6% |
| Long-term Debt | $1.19B | -1.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $438.0M | -40.9% |
| Capital Expenditures | $169.8M | +24.2% |
| Investing Cash Flow | -$172.9M | +17.2% |
| Financing Cash Flow | -$212.7M | +52.6% |
| Free Cash Flow | $268.1M | -55.6% |
| -59.2% |
| Net Income | $159.6M | -49.6% |
| EPS (Basic) | $2.73 | -50.0% |
| EPS (Diluted) | $2.69 | -50.1% |
| Total Liabilities |
| $2.93B |
| +12.4% |
| Stockholders' Equity | $2.63B | +5.5% |